1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Placebo to ACV: new trials by email Literature Review of Placebo to ACV trials Research Report on Placebo to ACV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002) Letermovir, Valganciclovir, Acyclovir (ACV) - CMV Disease | Phase 3 | Completed | Merck Sharp & Dohme LLC | 601 | 2018-05-03 | 2023-07-28 |
Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Canada (1) · Colombia (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Mexico (1) · New Zealand (1) · Poland (1) · Spain (1) · United Kingdom (1)
PMID 37279999, PMID 38700045, PMID 38853607, PMID 41321121, PMID 42639594
2017 (1)